Literature DB >> 21685329

Experimental hypertension triggers varicosis-like maladaptive venous remodeling through activator protein-1.

Anja Feldner1, Hannes Otto, Stephan Rewerk, Markus Hecker, Thomas Korff.   

Abstract

An increase in circumferential wall tension (CWT) is an important determinant of vascular remodeling during hypertension or arteriosclerosis but also arteriogenesis. Although pivotal for such processes, the effect of this biomechanical force on venous remodeling has not yet been delineated. To this end, we raised the filling pressure in veins of the mouse auricle, which led to a 2.5-fold enlargement of these blood vessels within 4 d along with an increase in smooth muscle cell proliferation, matrix metalloproteinase 2 (MMP-2) expression and gelatinase activity. These changes were likewise observed in tissue samples of human varicose veins. Topical treatment of the auricles with a decoy oligonucleotide-neutralizing activator protein 1 (AP-1) inhibited these effects. Likewise, proliferation, MMP-2 expression, and gelatinase activity in both native and cultured venous smooth muscle cells exposed to enhanced stretch was decreased by up to 80% through inhibiting AP-1. In contrast, mutant control oligonucleotides had no effect on smooth muscle cell activation. These findings indicate that an increase in venous filling pressure and thus CWT is sufficient to activate AP-1, which, in turn, triggers varicose remodeling through fuelling MMP-2 activity and smooth muscle cell hyperplasia in the venous vessel wall.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21685329     DOI: 10.1096/fj.11-185975

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  12 in total

Review 1.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

2.  Biomechanical Stretch Induces Inflammation, Proliferation, and Migration by Activating NFAT5 in Arterial Smooth Muscle Cells.

Authors:  Wei Cao; Donghui Zhang; Qiannan Li; Yue Liu; Shenhong Jing; Jinjin Cui; Wei Xu; Shufeng Li; Jingjin Liu; Bo Yu
Journal:  Inflammation       Date:  2017-12       Impact factor: 4.092

Review 3.  Vein graft failure.

Authors:  Christopher D Owens; Warren J Gasper; Amreen S Rahman; Michael S Conte
Journal:  J Vasc Surg       Date:  2013-10-03       Impact factor: 4.268

4.  A novel role for relaxin-2 in the pathogenesis of primary varicosis.

Authors:  Julia Adams; Sarah Schott; Arno Bern; Matthias Renz; Kristian Ikenberg; Claus Garbe; Christian Busch
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

5.  TonEBP/NFAT5 regulates ACTBL2 expression in biomechanically activated vascular smooth muscle cells.

Authors:  Maren Hödebeck; Clemens Scherer; Andreas H Wagner; Markus Hecker; Thomas Korff
Journal:  Front Physiol       Date:  2014-12-03       Impact factor: 4.566

6.  Varicose Remodeling of Veins Is Suppressed by 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors.

Authors:  Johannes Eschrich; Ralph Meyer; Hanna Kuk; Andreas H Wagner; Thomas Noppeney; Sebastian Debus; Markus Hecker; Thomas Korff
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

7.  Magnolol inhibits venous remodeling in mice.

Authors:  Hanna Kuk; Caroline Arnold; Ralph Meyer; Markus Hecker; Thomas Korff
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

8.  Glycyrrhetinic Acid Antagonizes Pressure-Induced Venous Remodeling in Mice.

Authors:  Hanna Kuk; Caroline Arnold; Andreas H Wagner; Markus Hecker; Carsten Sticht; Thomas Korff
Journal:  Front Physiol       Date:  2018-04-04       Impact factor: 4.566

9.  AP-1 Oligodeoxynucleotides Reduce Aortic Elastolysis in a Murine Model of Marfan Syndrome.

Authors:  Rawa Arif; Marcin Zaradzki; Anca Remes; Philipp Seppelt; Reiner Kunze; Hannes Schröder; Simon Schwill; Stephan M Ensminger; Peter N Robinson; Matthias Karck; Oliver J Müller; Markus Hecker; Andreas H Wagner; Klaus Kallenbach
Journal:  Mol Ther Nucleic Acids       Date:  2017-09-20

Review 10.  Latest Innovations in the Treatment of Venous Disease.

Authors:  Robert R Attaran
Journal:  J Clin Med       Date:  2018-04-11       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.